Tech Session VI: Immuno Delivery III

Chair(s)

• 

  Yang Shi, PhD (he/him/his)

  Prof. Dr.
  Department of Polymer Therapeutics
  RWTH Aachen University
  Aachen, Germany

Co-Chair(s)

• 

  Jai Prakash, PhD (he/him/his)

  Professor and Chair
  University of Twente
  Enschede, Netherlands

Targeting immune cells in peripheral tissues and at the sites of immunological reactions, modification of the innate and adaptive immunity, immunomodulation of the tumor microenvironment, and immunotherapy.

Presentations:

• 4:34 PM - 4:59 PM EDT

  Engineering Tolerance: Acetalated Dextran Microparticles in the Generation of B-regs and T-regs
  

  Invited Speaker: Kristy Ainslie, PhD (she/her/hers) – Division of Pharmacoengineering & Molecular Pharmaceutics, UNC
• 4:59 PM - 5:24 PM EDT

  The immunological aspects of immune checkpoint blockade
  

  Invited Speaker: Yuval Shaked, PhD (he/him/his) – Technion
• 5:24 PM - 5:35 PM EDT

  CD47-Targeted Antibody Polymer-Drug Conjugates: Immune Checkpoint Blockade and Targeted Cytotoxicity
  

  Oral Abstract Speaker: Jiahui Li, PharmD – University of Utah
• 5:35 PM - 5:46 PM EDT

  Prodrug-tethered lipid nanoparticles for synergistic mRNA cancer immunotherapy
  

  Oral Abstract Speaker: Qiangqiang Shi, PhD (he/him/his) – University of Pennsylvania
• 5:46 PM - 5:57 PM EDT

  A DC-targeted nano-vaccine to overcome immune suppression and enhance the SoC efficacy for PDAC
  

  Oral Abstract Speaker: Ron Kleiner – Tel Aviv University
• 5:57 PM - 6:08 PM EDT

  Aromatic mRNA-LNP platform confers vaccine protection with reduced off-target delivery
  

  Oral Abstract Speaker: Hannah M. Yamagata (she/her/hers) – University of Pennsylvania
• 6:08 PM - 6:19 PM EDT

  Anti-tumor activity of an RNA-encoded antibody combining T-cell engagement and checkpoint inhibition
  

  Oral Abstract Speaker: Philipp Lapuhs (he/him/his) – University of Santiago de Compostela
• 6:19 PM - 6:30 PM EDT

  Immunomodulatory nano-in-microgel to prevent extrahepatic islet graft rejection in type 1 diabetes
  

  Oral Abstract Speaker: Dhanashree H. Surve, M.Pharm, PhD (she/her/hers) – University of Miami